Kala Pharmaceuticals, Inc Kala (NASDAQ: KALA) Decides to Sell EYSUVIS and INVELTYS Kala Pharmaceuticals, Inc. (NASDAQ: KALA) confirmed that it has decided to sell its commercial portfolio and related intellectual property assets. The company has inked an agreement with Alcon Inc to
